Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

AT&T Stock Is a Buy, According to Wall Street


Shares of telecom giant (NYSE: T) have greatly underperformed the broader stock market this year. While the S 500 has logged a 17% gain year to date, the stock has shed about 20% of its value.

Investors have some legitimate concerns. For one, AT's balance sheet is loaded with debt. Net debt totaled $132 billion AT the end of the second quarter, approximately unchanged over the prior year. Although the company plans to knock down this debt over the next two years, interest rates have spiked. As it refinances its debt, the company will likely need to accept higher rates.

There's also the issue of lead-coated telecom cables. The Wall Street Journal reported in July that telecom companies including AT had left miles of lead-coated cables in the ground, underwater, and on overhead poles.

Continue reading


Source Fool.com

Allergy Therapeutics PLC Aktie

0,062 €
6,03 %
Ein erheblicher Kursanstieg bei Allergy Therapeutics PLC heute, um 6,03 %.

Like: 0
T
Teilen

Kommentare